{"id":535600,"date":"2021-09-08T08:34:05","date_gmt":"2021-09-08T12:34:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/"},"modified":"2021-09-08T08:34:05","modified_gmt":"2021-09-08T12:34:05","slug":"scynexis-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"SCYNEXIS to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">JERSEY CITY, N.J., Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; SCYNEXIS, Inc. (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GhStoe8odIXuA3pr3MfrK6SWuZmegorJkPjtgXV7N1Ee5hH-iQ5x_hHQ3gyC2LhSWLYwy8y0bjZbVDlOOkrahdB_5ahb8igfGM1LpU3m3LemH6BLU84ZSd-lZig3tyOY\" rel=\"nofollow noopener\" target=\"_blank\">SCYX<\/a>), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Company will participate in the following virtual investor conferences in September.<\/p>\n<p>Presentation details can be found below:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright 23<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Investment Conference<\/strong><br \/>\n          <br \/>Format: On demand presentation and 1-on-1 meetings<br \/>Date and Time: Presentation available Monday, September 13 at 7 am ET, 1-on-1 meetings September 13-15<br \/><a href=\"https:\/\/my.ct.events\/register.aspx?meid=b4a701b0-71a0-4667-9082-299f545e8cf8&amp;rpid=f0d11ebc-486e-4073-8ea7-9bb41337715e\" rel=\"nofollow noopener\" target=\"_blank\">Registration Link<\/a><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Cantor Fitzgerald Virtual Global Healthcare Conference<\/strong><br \/>\n          <br \/>Format: Live presentation and 1-on-1 meetings<br \/>Date and Time: Thursday, September 30 from 2:40-3:10 pm ET (Track 2)<\/li>\n<\/ul>\n<p align=\"justify\">The presentations and archived webcasts can be found on the SCYNEXIS website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hMURjaD1mNlV_coAkc3imy7gXTUputSoaHhnIKs83GeZskMTZP1tBRYLRj-ja9yxeM_zJZMbwwXA-Ul5lFi37KQXrY4579yfaoLmBHNGdSifz8eTcUkJ-ml6X73YkjWdr4X1fytYdqNulL_HNWML1A==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.scynexis.com\/news-media\/events<\/a> for 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0SCYNEXIS<\/strong><br \/>\n        <br \/>SCYNEXIS, Inc.\u00a0(NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. SCYNEXIS scientists are developing the company\u2019s lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. SCYNEXIS has initiated the launch of its first commercial product in the U.S., <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DbwrDLU0BXTBOFdlKIbRUbIM6BH-UymKNNsaSrb4hLHvv08WrjjlWVQ24SFgD02Z0uC4Kqg8u8s5nPgujv4LRA==\" rel=\"nofollow noopener\" target=\"_blank\">BREXAFEMME<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k3oylDA7fDkiJHhRX1ILZal0aPqu74tukDbGqoMFAk_z7D5o-a0wvqkOhJUE3D-vzeT0LfDnMpRJkxC57I9-JQ==\" rel=\"nofollow noopener\" target=\"_blank\"><sup>\u00ae<\/sup><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g0uMQOjiJCvC15B-lZUAQtHrAAJz7ml73gfNDkB5Aa6Zz4NQ_0f7jTRWTcuJAGxCoLzLkw2-yGbZRjuHs_7NqRNgthu5Bx_wwt6lcK-PuqI=\" rel=\"nofollow noopener\" target=\"_blank\">\u00a0(ibrexafungerp tablets)<\/a>, which was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. In addition, late-stage clinical investigation of ibrexafungerp for the prevention of recurrent vulvovaginal candidiasis (rVVC) and the treatment of life-threatening invasive fungal infections in hospitalized patients is ongoing. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s9ovzj0e5uyAi9TojnIoXX15nFcoZ17Bjdq0xchVI_ibxDvqpFBNgRgywxrWxnQCnlYa6dYBGxCnKzmwb-uRfQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.scynexis.com<\/a>.\u00a0<\/p>\n<p>\n        <strong><br \/>\n          <u>CONTACT<\/u><br \/>\n        <\/strong><br \/>\n        <strong>:\u00a0<\/strong><br \/>\n        <br \/>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Irina Koffler<br \/>LifeSci Advisors<br \/>Tel: (646) 970-4681<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fgcRhD275wJp12VRgawF3gWREIiMqh_OKQvRJ26g3I58Xy-UobtPZUCOmHt1qQxLtE8tRv9g7RO-WFPzRzc9xo4ayblIrtz2qdSdOcgbvRAVwWAU82bskN3HFZSnQolf\" rel=\"nofollow noopener\" target=\"_blank\">ikoffler@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Gloria Gasaatura<br \/>LifeSci Communications<br \/>Tel: (646) 970-4688<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AEAd00mF0MxhnxT0s8FZJAn1Ryl_pGWFWfObexpBYY8eJJ7Tq6t1HEM8cTbQY2fNuxVM2OzjXwrko12GZVAM-0uDxpwoHFFldEFnluzJuOfj1-6FRZ04CloMPpPh7xmo\" rel=\"nofollow noopener\" target=\"_blank\">ggasaatura@lifescicomms.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTNjMTIzMmUtNDFmZS00NTY5LTk0M2YtYWQwZTQxODg4MjcxLTUwMDA3MDcxOA==\/tiny\/Scynexis-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JERSEY CITY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Company will participate in the following virtual investor conferences in September. Presentation details can be found below: H.C. Wainwright 23 rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetingsDate and Time: Presentation available Monday, September 13 at 7 am ET, 1-on-1 meetings September 13-15Registration Link Cantor Fitzgerald Virtual Global Healthcare Conference Format: Live presentation and 1-on-1 meetingsDate and Time: Thursday, September 30 from 2:40-3:10 pm ET (Track 2) The presentations and archived webcasts can be found on the SCYNEXIS website at: https:\/\/www.scynexis.com\/news-media\/events for 30 days following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SCYNEXIS to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535600","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JERSEY CITY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Company will participate in the following virtual investor conferences in September. Presentation details can be found below: H.C. Wainwright 23 rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetingsDate and Time: Presentation available Monday, September 13 at 7 am ET, 1-on-1 meetings September 13-15Registration Link Cantor Fitzgerald Virtual Global Healthcare Conference Format: Live presentation and 1-on-1 meetingsDate and Time: Thursday, September 30 from 2:40-3:10 pm ET (Track 2) The presentations and archived webcasts can be found on the SCYNEXIS website at: https:\/\/www.scynexis.com\/news-media\/events for 30 days following &hellip; Continue reading &quot;SCYNEXIS to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T12:34:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SCYNEXIS to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2021-09-08T12:34:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\",\"datePublished\":\"2021-09-08T12:34:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/scynexis-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCYNEXIS to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"JERSEY CITY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Company will participate in the following virtual investor conferences in September. Presentation details can be found below: H.C. Wainwright 23 rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetingsDate and Time: Presentation available Monday, September 13 at 7 am ET, 1-on-1 meetings September 13-15Registration Link Cantor Fitzgerald Virtual Global Healthcare Conference Format: Live presentation and 1-on-1 meetingsDate and Time: Thursday, September 30 from 2:40-3:10 pm ET (Track 2) The presentations and archived webcasts can be found on the SCYNEXIS website at: https:\/\/www.scynexis.com\/news-media\/events for 30 days following &hellip; Continue reading \"SCYNEXIS to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T12:34:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SCYNEXIS to Participate in Upcoming Investor Conferences","datePublished":"2021-09-08T12:34:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/","name":"SCYNEXIS to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==","datePublished":"2021-09-08T12:34:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA1MiM0Mzg1NDQ5IzUwMDA3MDcxOA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/scynexis-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SCYNEXIS to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535600"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535600\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}